REGENERON PHARMACEUT

REGN
Delayed Quote. Delayed  - 09/24 04:00:00 pm
638.9USD -1.18%

Turn to zoom
Prev.646.5100
Open644.3100
High644.3100
Low632.4450
Volume654 471
Latest news
1d ago
2d ago
3d ago
3d ago
Chart REGENERON PHARMACEUTICALS
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance681681680
Spread/Res.-6,2%-6,2%-6,0%
Spread/Supp.0,52%11%11%
Support636575575
Financials
Sales 2021 13 869 M - -
Net income 2021 6 943 M - -
Net cash 2021 6 794 M - -
P/E ratio 2021 10,1x
Yield 2021 -
Capitalization 66 425 M 66 425 M -
EV / Sales 2021 4,30x
EV / Sales 2022 4,68x
Nbr of Employees 9 635
Free-Float 82,0%
Company
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-09-27 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 638,90 $
Average target price 681,41 $
Spread / Average Target 6,65%